Found: 11
Select item for more details and to access through your institution.
PET measurement of cyclooxygenase-2 using a novel radioligand: upregulation in primate neuroinflammation and first-in-human study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
[ 11 C]deschloroclozapine is an improved PET radioligand for quantifying a human muscarinic DREADD expressed in monkey brain.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2021, v. 41, n. 10, p. 2571, doi. 10.1177/0271678X211007949
- By:
- Publication type:
- Article
Whole-Body PET Imaging in Humans Shows That <sup>11</sup>C-PS13 Is Selective for Cyclooxygenase-1 and Can Measure the In Vivo Potency of Nonsteroidal Antiinflammatory Drugs.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 1, p. 159, doi. 10.2967/jnumed.122.264061
- By:
- Publication type:
- Article
Whole-body PET imaging in humans shows that <sup>11</sup>C-PS13 is selective for cyclooxygenase-1 and can measure the in vivo potency of nonsteroidal anti-inflammatory drugs.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264061
- By:
- Publication type:
- Article
Whole-body PET imaging in humans shows that 11C-PS13 is selective for cyclooxygenase-1 and can measure the in vivo potency of nonsteroidal anti-inflammatory drugs.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.264061
- By:
- Publication type:
- Article
Whole-body PET imaging in humans shows that <sup>11</sup>C-PS13 is selective for cyclooxygenase-1 and can measure the in vivo potency of nonsteroidal anti-inflammatory drugs.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.122.264061
- By:
- Publication type:
- Article
Evaluation of Two Potent and Selective PET Radioligands to Image COX-1 and COX-2 in Rhesus Monkeys.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 12, p. 1907, doi. 10.2967/jnumed.118.211144
- By:
- Publication type:
- Article
<sup>11</sup>C-ER176, a Radioligand for 18-kDa Translocator Protein, Has Adequate Sensitivity to Robustly Image All Three Affinity Genotypes in Human Brain.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 2, p. 320, doi. 10.2967/jnumed.116.178996
- By:
- Publication type:
- Article
The 5-HT<sub>1A</sub> Receptor PET Radioligand <sup>11</sup>C-CUMI-101 Has Significant Binding to α<sub>1</sub>-Adrenoceptors in Human Cerebellum, Limiting Its Use as a Reference Region.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 12, p. 1945, doi. 10.2967/jnumed.116.174151
- By:
- Publication type:
- Article
<sup>11</sup>C-CUMI-101, a PET Radioligand, Behaves as a Serotonin 1A Receptor Antagonist and Also Binds to α<sub>1</sub> Adrenoceptors in Brain.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 1, p. 141, doi. 10.2967/jnumed.113.125831
- By:
- Publication type:
- Article
2-(4-Methylsulfonylphenyl)pyrimidines as Prospective Radioligands for Imaging Cyclooxygenase-2 with PET—Synthesis, Triage, and Radiolabeling.
- Published in:
- Molecules, 2018, v. 23, n. 11, p. 2850, doi. 10.3390/molecules23112850
- By:
- Publication type:
- Article